The global biologics Contract Development and Manufacturing Organization (CDMO) market is projected to grow from $23 billion in 2025 to $62 billion by 2034, at a CAGR of 11.7%. Growth is fueled by increased outsourcing from pharma and biotech firms, expanding biologics pipelines, rising oncology treatment demand, and biosimilar development. North America leads the market, while Asia-Pacific is the fastest-growing region. Key challenges include high capital costs and regulatory complexities, but strong demand for monoclonal antibodies and advanced therapies supports sustained expansion.
The biologics CDMO market outlook shows strong growth projections, reaching USD 62 billion by 2034 with an 11.7% CAGR. For readers following health-sector stocks on Pluang, here is the market snapshot as of Oct 14, 2026 17:11 WIB: out of 150 priced stocks, 98 rose and 44 fell. Novartis AG (NVS) rose 1.69% to USD 144.82 with a typical hold time of 82 days and 82% sell order activity, contrasting with ClearPoint Neuro Inc (CLPT) which gained 1.53% to USD 9.96 but had a much shorter hold time of 10 days and 100% buy orders. Quest Diagnostics Inc (DGX) declined 1.52% to USD 227.06 with a hold time of 56 days and full buy order activity.
CodeWall Ltd. has emerged from stealth with $4 million in pre-seed funding to develop AI-powered autonomous attack agents that simulate real-world cyberattacks on enterprises. These agents start from outside the network with no insider access, contin...
Matchpoint Therapeutics has appointed John O’Malley, M.D., Ph.D., as its Chief Medical Officer. Dr. O’Malley brings extensive experience in immunology and clinical development from his previous roles at CRISPR Therapeutics and Sanofi. His leadership ...
Orvida Pharma announced that the FDA has accepted its lead drug candidate KM-023 (ontivatrep) into the Rare Disease Evidence Principles (RDEP) process for treating Olmsted syndrome, a rare genetic skin disorder. This acceptance allows Orvida to engag...
DMC Global Inc. will announce its financial results for the third quarter ending September 30, 2026, on October 27 after the stock market closes. The company will hold a conference call and webcast to discuss the results, providing investors with ins...
Radware introduced its Model Context Protocol (MCP) Server Protection solution to help organizations secure the integration layer where AI agents connect to enterprise applications and workflows. This new security tool provides visibility into MCP in...
